XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance, common stock (in shares) at Jun. 30, 2023 [1]   296,846,217      
Beginning balance at Jun. 30, 2023 $ 2,534,183 $ 3 $ 5,140,850 $ (2,591,247) $ (15,423)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   495,350      
Issuance of common stock upon exercise of stock options 3,625   3,625    
Vesting of restricted stock units (in shares) [1]   3,740,320      
Vesting of warrants for common stock 95,910   95,910    
Stock-based compensation 151,162   151,162    
Tax withholding on stock-based compensation (36,515)   (36,515)    
Foreign currency translation adjustments (11,898)       (11,898)
Unrealized gain (loss) on securities available for sale 1,353       1,353
Gain (loss) on cash flow hedges 763       763
Net income (loss) (171,783)     (171,783)  
Ending balance, common stock (in shares) at Sep. 30, 2023 [1]   301,081,887      
Ending balance at Sep. 30, 2023 2,566,800 $ 3 5,355,032 (2,763,030) (25,205)
Beginning balance, common stock (in shares) at Jun. 30, 2023 [1]   296,846,217      
Beginning balance at Jun. 30, 2023 2,534,183 $ 3 5,140,850 (2,591,247) (15,423)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Foreign currency translation adjustments 1,926        
Net income (loss) (338,685)        
Ending balance, common stock (in shares) at Dec. 31, 2023 [1]   305,534,346      
Ending balance at Dec. 31, 2023 2,634,884 $ 3 5,571,955 (2,929,932) (7,142)
Beginning balance, common stock (in shares) at Sep. 30, 2023 [1]   301,081,887      
Beginning balance at Sep. 30, 2023 2,566,800 $ 3 5,355,032 (2,763,030) (25,205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   1,922,621      
Issuance of common stock upon exercise of stock options 17,419   17,419    
Issuance of common stock, employee share purchase plan (in shares) [1]   333,847      
Issuance of common stock, employee share purchase plan 4,137   4,137    
Vesting of restricted stock units (in shares) [1]   2,195,991      
Vesting of warrants for common stock 114,705   114,705    
Stock-based compensation 119,821   119,821    
Tax withholding on stock-based compensation (39,159)   (39,159)    
Foreign currency translation adjustments 13,824       13,824
Unrealized gain (loss) on securities available for sale 4,853       4,853
Gain (loss) on cash flow hedges (614)       (614)
Net income (loss) (166,902)     (166,902)  
Ending balance, common stock (in shares) at Dec. 31, 2023 [1]   305,534,346      
Ending balance at Dec. 31, 2023 2,634,884 $ 3 5,571,955 (2,929,932) (7,142)
Beginning balance, common stock (in shares) at Jun. 30, 2024 [1]   311,053,031      
Beginning balance at Jun. 30, 2024 2,731,989 $ 3 5,862,555 (3,109,004) (21,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   432,277      
Issuance of common stock upon exercise of stock options 3,596   3,596    
Vesting of restricted stock units (in shares) [1]   2,492,095      
Vesting of warrants for common stock 107,263   107,263    
Stock-based compensation 143,711   143,711    
Tax withholding on stock-based compensation (63,208)   (63,208)    
Foreign currency translation adjustments 8,346       8,346
Unrealized gain (loss) on securities available for sale 5,589       5,589
Gain (loss) on cash flow hedges (1,492)       (1,492)
Net income (loss) (100,222)     (100,222)  
Ending balance, common stock (in shares) at Sep. 30, 2024 [1]   313,977,403      
Ending balance at Sep. 30, 2024 2,835,572 $ 3 6,053,917 (3,209,226) (9,122)
Beginning balance, common stock (in shares) at Jun. 30, 2024 [1]   311,053,031      
Beginning balance at Jun. 30, 2024 $ 2,731,989 $ 3 5,862,555 (3,109,004) (21,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 3,211,902        
Foreign currency translation adjustments $ (27,123)        
Net income (loss) (19,862)        
Ending balance, common stock (in shares) at Dec. 31, 2024 [1]   315,735,274      
Ending balance at Dec. 31, 2024 2,785,540 $ 3 5,961,956 (3,128,866) (47,553)
Beginning balance, common stock (in shares) at Sep. 30, 2024 [1]   313,977,403      
Beginning balance at Sep. 30, 2024 2,835,572 $ 3 6,053,917 (3,209,226) (9,122)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) [1]   2,762,075      
Issuance of common stock upon exercise of stock options 30,700   30,700    
Issuance of common stock, employee share purchase plan (in shares) [1]   204,650      
Issuance of common stock, employee share purchase plan 5,092   5,092    
Repurchases of common stock (in shares) [1]   (3,526,590)      
Repurchases of common stock (250,000)   (250,000)    
Vesting of restricted stock units (in shares) [1]   2,317,736      
Vesting of warrants for common stock 86,776   86,776    
Stock-based compensation 130,806   130,806    
Tax withholding on stock-based compensation (95,335)   (95,335)    
Foreign currency translation adjustments (35,469)       (35,469)
Unrealized gain (loss) on securities available for sale (2,873)       (2,873)
Gain (loss) on cash flow hedges (89)       (89)
Net income (loss) 80,360     80,360  
Ending balance, common stock (in shares) at Dec. 31, 2024 [1]   315,735,274      
Ending balance at Dec. 31, 2024 $ 2,785,540 $ 3 $ 5,961,956 $ (3,128,866) $ (47,553)
[1] The share amounts listed above combine Class A and Class B stock.